Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003656 · ClinicalTrials.gov registry record · Phase 2

Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer

A Phase 2 study of Kidney Cancer, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
Phase 2
Development phase
26
Enrollment target
2
Study locations

NCT00003656 is a Phase 2 study of Kidney Cancer that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 26 participants, below the 880-participant average among 60 other Kidney Cancer trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003656, a Phase 2 study of Kidney Cancer, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
Phase 2
Development phase
26 participants
Enrollment target
2
Study locations

Study Summary

RATIONALE: Tretinoin may help kidney cancer cells develop into normal cells. Interferon alfa may interfere with the growth of cancer cells. PURPOSE: Phase II trial to study the effectiveness of liposomal tretinoin plus interferon alfa in treating patients who have metastatic kidney cancer.

Conditions Studied

Kidney Cancer

Interventions

  • BIOLOGICAL recombinant interferon alfa
  • DRUG tretinoin liposome

Study Locations (2)

New York

  • New York Weill Cornell Cancer Center at Cornell University - New York
  • Herbert Irving Comprehensive Cancer Center at Columbia University - New York

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 1999-01
Est. Completion 2008-05
Phase Phase 2

Sponsor

Weill Medical College of Cornell University

701 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00003656

The ClinicalTrials.gov registry entry for NCT00003656 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 880-participant average among 60 other Kidney Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Cancer appearing as the primary indexed condition, and to 2 interventions - of which recombinant interferon alfa is the first listed.

NCT00003656 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00003656 about?

NCT00003656 is a clinical study titled "Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer". RATIONALE: Tretinoin may help kidney cancer cells develop into normal cells. Interferon alfa may interfere with the growth of cancer cells. PURPOSE: Phase II trial to study the effectiveness of liposomal tretinoin plus interferon alfa in treating patients who have metastatic kidney cancer.

What is the current status of trial NCT00003656?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 1999-01. Estimated completion is 2008-05.

What conditions does trial NCT00003656 study?

This clinical trial studies the following conditions: Kidney Cancer.

What interventions are being tested in trial NCT00003656?

The interventions under investigation include: recombinant interferon alfa (BIOLOGICAL), tretinoin liposome (DRUG).

Who is sponsoring clinical trial NCT00003656?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00003656 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Cancer

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.